We are live on ! Find out more
TAM

TFG Asset Management Portfolio holdings

AUM $635M
1-Year Est. Return 28.07%
This Fund
S&P 500
This Quarter Est. Return
+10.01%
1 Year Est. Return
+28.07%
3 Year Est. Return
+72.07%
5 Year Est. Return
+87.41%
10 Year Est. Return
+132.97%
AUM
$621M
AUM Growth
+$183M
Cap. Flow
+$15.3M
Cap. Flow %
2.47%
Top 10 Hldgs %
84.3%
Holding
40
New
7
Increased
12
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
PATH icon
UiPath
PATH
+$57.3M
2
WK icon
Workiva
WK
+$10.3M
3
SRRK icon
Scholar Rock
SRRK
+$3.25M
4
TARS icon
Tarsus Pharmaceuticals
TARS
+$3.22M
5
DYN icon
Dyne Therapeutics
DYN
+$1.52M

Top Sells

Rank Stock Value
1
INFA
Informatica
INFA
+$14M
2
BVN icon
Compañía de Minas Buenaventura
BVN
+$867K
3
OTLY
Oatly Group
OTLY
+$798K
4
KROS icon
Keros Therapeutics
KROS
+$743K
5
CCJ icon
Cameco
CCJ
+$108K

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.87%
2 Technology 35.85%
3 Healthcare 11.95%
4 Energy 8.07%
5 Materials 0.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PATH icon
1
UiPath
PATH
$9.4B
$176M 28.3%
13,722,244
+4,772,244
+53% +$57.3M
HYG icon
2
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
$66.3M 10.68%
822,000
-779,900
-49% -$61.4M
KGEI
3
Kolibri Global Energy
KGEI
$209M
$48.7M 7.84%
7,068,857
-1,711
-0% -$11.8K
AUTL
4
Autolus Therapeutics
AUTL
$623M
$21.7M 3.49%
9,500,000
+900,000
+10% +$1.49M
CXM icon
5
Sprinklr
CXM
$1.91B
$18.6M 3%
2,200,000
– –
LYFT icon
6
Lyft
LYFT
$6.7B
$15.8M 2.54%
1,000,000
– –
WK icon
7
Workiva
WK
$4.31B
$10.3M 1.65%
+150,000
New +$10.3M
TARS icon
8
Tarsus Pharmaceuticals
TARS
$3.15B
$10.1M 1.63%
250,000
+71,530
+40% +$3.22M
ANNX icon
9
Annexon
ANNX
$942M
$6.74M 1.09%
2,810,000
+160,000
+6% +$321K
CLDX icon
10
Celldex Therapeutics
CLDX
$3.07B
$6.43M 1.04%
316,150
+55,150
+21% +$1.07M
HYG icon
11
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.6B
$5.54M 0.89%
68,660
+5,518
+9% +$435K
TECX
12
Tectonic Therapeutic
TECX
$696M
$4.55M 0.73%
228,832
+41,332
+22% +$838K
AXSM icon
13
Axsome Therapeutics
AXSM
$10.4B
$4.34M 0.7%
41,531
+7,725
+23% +$818K
SRRK icon
14
Scholar Rock
SRRK
$7.04B
$3.67M 0.59%
+103,482
New +$3.25M
ACAD icon
15
Acadia Pharmaceuticals
ACAD
$5.02B
$3.48M 0.56%
161,396
+54,396
+51% +$1.01M
PHVS icon
16
Pharvaris
PHVS
$2.48B
$3.31M 0.53%
188,100
+61,105
+48% +$984K
RLAY icon
17
Relay Therapeutics
RLAY
$4.11B
$2.42M 0.39%
699,000
+80,000
+13% +$238K
IMVT icon
18
Immunovant
IMVT
$8.51B
$2.37M 0.38%
147,817
+16,650
+13% +$252K
SNOW icon
19
Snowflake
SNOW
$114B
$2.24M 0.36%
10,000
– –
KROS icon
20
Keros Therapeutics
KROS
$219M
$1.71M 0.28%
128,000
-55,000
-30% -$743K
CCJ icon
21
Cameco
CCJ
$43.6B
$1.43M 0.23%
19,280
-2,020
-9% -$108K
AMLX icon
22
Amylyx Pharmaceuticals
AMLX
$3.87B
$1.4M 0.23%
+218,750
New +$1.06M
DYN icon
23
Dyne Therapeutics
DYN
$4.68B
$1.32M 0.21%
+138,375
New +$1.52M
HBM icon
24
Hudbay
HBM
$13B
$1.14M 0.18%
107,000
– –
ALKS icon
25
Alkermes
ALKS
$7.95B
$447K 0.07%
+15,632
New +$465K
1
2

Similar funds

GRR
Golden Reserve Retirement Dublin, Ohio $635M AUM 25.04% 1-Year Est. Return
GAM
Gould Asset Management Claremont, California $635M AUM 14.36% 1-Year Est. Return
MPIA
Mountain Pacific Investment Advisers Boise, Idaho $635M AUM 26.7% 1-Year Est. Return
AFG
Altiora Financial Group Lebanon, Ohio $634M AUM 13.93% 1-Year Est. Return
MWA
Martel Wealth Advisors Vancouver, Washington $636M AUM 12.74% 1-Year Est. Return
MCM
Maytus Capital Management New York $636M AUM 131.32% 1-Year Est. Return
MAM
Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return
BAM
BOCHK Asset Management Hong Kong $634M AUM 64.99% 1-Year Est. Return

TFG Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, TFG Asset Management held 40 positions worth $621M, up 42% from $438M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

TFG Asset Management's Q2 2025 filing shows 7 new, 12 increased, 5 reduced and 3 closed positions. Its largest new stake was Workiva: 150,000 shares worth $10.3M. The largest sale was Informatica, an estimated $14M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.

  • TFG Asset Management's largest Q2 2025 buy was Workiva: 150,000 shares worth $10.3M.
  • TFG Asset Management added most to UiPath in Q2 2025, an estimated $57.3M increase.
  • TFG Asset Management's biggest Q2 2025 reduction was Keros Therapeutics, cutting an estimated $743K.
  • TFG Asset Management fully exited Informatica in Q2 2025, selling an estimated $14M.
  • TFG Asset Management's ten largest holdings make up 84% of its $621M portfolio in Q2 2025.
  • TFG Asset Management opened 7 new positions and closed 3 in Q2 2025.
  • TFG Asset Management's portfolio value rose 42% quarter-over-quarter to $621M.

Based on TFG Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.